333 results on '"Giammarco, Sabrina"'
Search Results
2. Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients
3. Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study
4. Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis
5. Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center
6. Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia
7. Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants
8. The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
9. The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center.
10. Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review.
11. Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma
12. Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
13. Posttransplant Autoimmune Hemolytic Anemia with Anti-D Specificity Successfully Treated with Daratumumab: A Case Report
14. Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up
15. Acute graft versus host disease 1976–2020: reduced incidence and predictive factors
16. Unselected donor‐derived hematopoietic stem cells boost for Chimeric Antigen Receptor T‐cell associated hematotoxicity
17. Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir‐exposed CMV‐free population receiving PTCy
18. Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study
19. Second haploidentical stem cell transplantation for primary graft failure
20. Advances in the Pathogenesis and Treatment of Immune-Mediated Aplastic Anemia
21. Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes?
22. Severe breakthrough hemolysis during compassionate use of Pegcetacoplan in paroxysmal nocturnal hemoglobinuria: managing an emergency.
23. CAR‐T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation.
24. Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management.
25. ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes
26. Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft‐versus‐host disease after allogeneic stem cell transplant
27. The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting
28. SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria
29. P1305: NEPA VERSUS ONDANSETRON FOR THE PREVENTION OF CINV IN PATIENTS WITH MULTIPLE MYELOMA OR LYMPHOMA UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION. A MONOCENTRIC REAL-LIFE EXPERIENCE.
30. Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management
31. Haploidentical bone marrow transplantation for AML in remission after TBF conditioning: a long-term follow-up
32. Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patients
33. Use of eltrombopag in aplastic anemia in Europe
34. Peripheral blood allogeneic stem cell mobilization: can we predict a suboptimal mobilization?
35. Effect of HLA Mismatch on Post-Transplant Infections in Allogeneic Hematopoietic Stem Cell Transplantation with PTCy-Based GvHD Prophylaxis
36. Safety and efficacy of SARS‐Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR‐T cell infusion
37. Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells
38. Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML
39. Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience
40. Deciphering Treatment Patterns in Non-Severe Aplastic Anemia: An International Observational Study
41. Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation
42. Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome
43. Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation
44. A common pattern of somatic mutations in t‐MDS / AML of patients treated with PARP inhibitors for metastatic ovarian cancer
45. Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients
46. Changes in protein serum levels during stem cell transplantation
47. Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells.
48. Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia
49. Salivary Proteomic Analysis and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
50. BLINATUMOMAB AS A SUCCESSFUL AND SAFE THERAPY IN A DOWN SYNDROME PATIENT WITH RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORTS AND LITERATURE. REVIEW
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.